Anti-inflammatory response to 1,8-Cineol and associated microbial communities in Otitis media patients.


Journal

Scientific reports
ISSN: 2045-2322
Titre abrégé: Sci Rep
Pays: England
ID NLM: 101563288

Informations de publication

Date de publication:
16 Jul 2024
Historique:
received: 18 03 2024
accepted: 11 07 2024
medline: 17 7 2024
pubmed: 17 7 2024
entrez: 16 7 2024
Statut: epublish

Résumé

Chronic Otitis Media (COM) is defined as long term inflammation and colonization with pathogenic bacteria due to a defect or retraction of the tympanic membrane. Surgical interventions are often augmented by antibiotic resistance development and therefore, off-label treatment using the natural drug 1,8-Cineol was carried out. All COM patients underwent antibiotic therapy and middle ear surgery and developed antibiotic resistances. Microbiological investigations from the auditory canal and stool samples were performed in correlation with the clinical course. Therapy of COM patients with 1,8-Cineol revealed a clear reduction of inflammatory microbes P. aeruginosa and Proteus mirabilis in ear samples as well as intestinal Prevotella copri, which was associated with an improved clinical outcome in certain individuals. The present off-label study revealed manifold anti-inflammatory effects of the natural monoterpene 1,8-Cineol in Otitis media patients. A better understanding of the underlying mechanisms will improve the current treatment options and possible forms of application of this natural drug.

Identifiants

pubmed: 39014066
doi: 10.1038/s41598-024-67498-5
pii: 10.1038/s41598-024-67498-5
doi:

Substances chimiques

Anti-Inflammatory Agents 0
Anti-Bacterial Agents 0

Types de publication

Journal Article

Langues

eng

Sous-ensembles de citation

IM

Pagination

16362

Subventions

Organisme : Cassella-med GmbH & Co. KG, Cologne, Germany
ID : FDE00400/01
Organisme : German Center for Infection Research
ID : TTU 08.826

Informations de copyright

© 2024. The Author(s).

Références

Rovers, M. M., Schilder, A. G., Zielhuis, G. A. & Rosenfeld, R. M. Otitis media. Lancet 363, 465–473 (2004).
pubmed: 14962529 doi: 10.1016/S0140-6736(04)15495-0
Bruchhage, K. L. et al. Hearing rehabilitation and microbial shift after middle ear surgery with Vibrant Soundbridge in patients with chronic otitis media. Eur. Arch. oto-rhino-laryngol. Off. J. Eur. Fed. Oto-Rhino-Laryngol. Soc. 280, 3107–3118 (2023).
doi: 10.1007/s00405-022-07795-9
Shi, X. Pathophysiology of the cochlear intrastrial fluid-blood barrier (review). Hear. Res. 338, 52–63 (2016).
pubmed: 26802581 pmcid: 5322264 doi: 10.1016/j.heares.2016.01.010
Hirose, K., Li, S. Z., Ohlemiller, K. K. & Ransohoff, R. M. Systemic lipopolysaccharide induces cochlear inflammation and exacerbates the synergistic ototoxicity of kanamycin and furosemide. J. Assoc. Res. Otolaryngol. JARO 15, 555–570 (2014).
pubmed: 24845404 doi: 10.1007/s10162-014-0458-8
Reiss, M. & Reiss, G. Presbyacusis: Pathogenesis and treatment. Med. Monatsschr. Pharm. 32, 221–225 (2009).
pubmed: 19554832
Monasta, L. et al. Burden of disease caused by otitis media: systematic review and global estimates. PloS one 7, e36226 (2012).
pubmed: 22558393 pmcid: 3340347 doi: 10.1371/journal.pone.0036226
Schilder, A. G. et al. Otitis media. Nat. Rev. Dis. Primers 2, 16063 (2016).
pubmed: 27604644 pmcid: 7097351 doi: 10.1038/nrdp.2016.63
Jiang, H. et al. Bacterial and fungal infections promote the bone erosion progression in acquired cholesteatoma revealed by metagenomic next-generation sequencing. Front. Microbiol. 12, 761111 (2021).
pubmed: 34803987 pmcid: 8604023 doi: 10.3389/fmicb.2021.761111
Kazmierczak, W. et al. Analysis of pathogens and antimicrobial treatment in different groups of patients with chronic otitis media. J. Laryngol. Otol. 136, 219–222 (2022).
pubmed: 34702380 doi: 10.1017/S0022215121003224
Chai, Y. et al. Intratympanic lipopolysaccharide elevates systemic fluorescent gentamicin uptake in the cochlea. Laryngoscope 131, E2573–E2582 (2021).
pubmed: 33956344 pmcid: 8453712 doi: 10.1002/lary.29610
Forge, A. & Schacht, J. Aminoglycoside antibiotics. Audiol. Neurootol. 5, 3–22 (2000).
pubmed: 10686428 doi: 10.1159/000013861
Dai, C. F., Mangiardi, D., Cotanche, D. A. & Steyger, P. S. Uptake of fluorescent gentamicin by vertebrate sensory cells in vivo. Hear. Res. 213, 64–78 (2006).
pubmed: 16466873 pmcid: 2424187 doi: 10.1016/j.heares.2005.11.011
Di Pietro, P. et al. Monitoring adherence to guidelines of antibiotic use in pediatric pneumonia: The MAREA study. Ital. J. Pediatrics 43, 113 (2017).
doi: 10.1186/s13052-017-0432-2
Khatun, M. R., Alam, K. M. F., Naznin, M. & Salam, M. A. Microbiology of chronic suppurative otitis media: An update from a tertiary care hospital in Bangladesh. Pak. J. Med. Sci. 37, 821–826 (2021).
pubmed: 34104172 pmcid: 8155403 doi: 10.12669/pjms.37.3.3942
van Olst, L. et al. Contribution of gut microbiota to immunological changes in alzheimer’s disease. Front. Immunol. 12, 683068 (2021).
pubmed: 34135909 pmcid: 8200826 doi: 10.3389/fimmu.2021.683068
Pu, Q. et al. Gut microbiota regulate gut-lung axis inflammatory responses by mediating ILC2 compartmental migration. J. Immunol. 207, 257–267 (2021).
pubmed: 34135060 doi: 10.4049/jimmunol.2001304
Ke, S. et al. Integrating gut microbiome and host immune markers to understand the pathogenesis of Clostridioides difficile infection. Gut Microbes 13, 1–18 (2021).
pubmed: 34132169 doi: 10.1080/19490976.2021.1935186
Kociszewska, D. & Vlajkovic, S. Age-related hearing loss: The link between inflammaging, immunosenescence, and gut dysbiosis. Int. J. Mol. Sci. 23, 7348 (2022).
pubmed: 35806352 pmcid: 9266910 doi: 10.3390/ijms23137348
Juergens, U. R. Anti-inflammatory properties of the monoterpene 1.8-cineole: Current evidence for co-medication in inflammatory airway diseases. Drug Res. 64, 638–646 (2014).
doi: 10.1055/s-0034-1372609
Juergens, U. R., Stober, M. & Vetter, H. Inhibition of cytokine production and arachidonic acid metabolism by eucalyptol (1.8-cineole) in human blood monocytes in vitro. Eur. J. Med. Res. 3, 508–510 (1998).
pubmed: 9810029
Ocana, A. & Reglero, G. Effects of thyme extract oils (from thymus vulgaris, thymus zygis, and thymus hyemalis) on cytokine production and gene expression of oxLDL-stimulated THP-1-macrophages. J. Obes. 2012, 104706 (2012).
pubmed: 22577523 pmcid: 3345235 doi: 10.1155/2012/104706
Juergens, U. R. et al. Inhibitory activity of 1,8-cineol (eucalyptol) on cytokine production in cultured human lymphocytes and monocytes. Pulm. Pharmacol. Ther. 17, 281–287 (2004).
pubmed: 15477123 doi: 10.1016/j.pupt.2004.06.002
MacKenzie, C. et al. Determination of orally administered 1,8-Cineol in nasal polyp tissues from chronic rhinosinusitis patients using gas chromatography: Mass spectrometry. Sci. Rep. 13, 3605 (2023).
pubmed: 36869061 pmcid: 9984394 doi: 10.1038/s41598-023-29941-x
Moo, C. L. et al. Antimicrobial activity and mode of action of 1,8-cineol against carbapenemase-producing Klebsiella pneumoniae. Sci. Rep. 11, 20824 (2021).
pubmed: 34675255 pmcid: 8531306 doi: 10.1038/s41598-021-00249-y
Juergens, U. R. et al. Anti-inflammatory activity of 1.8-cineol (eucalyptol) in bronchial asthma: A double-blind placebo-controlled trial. Respir. Med. 97, 250–256 (2003).
pubmed: 12645832 doi: 10.1053/rmed.2003.1432
Bruchhage, K. L. et al. 1,8-cineol inhibits the Wnt/beta-catenin signaling pathway through GSK-3 dephosphorylation in nasal polyps of chronic rhinosinusitis patients. Eur. J. Pharmacol. 835, 140–146 (2018).
pubmed: 30081034 doi: 10.1016/j.ejphar.2018.07.060
Schurmann, M. et al. The therapeutic effect of 1,8-cineol on pathogenic bacteria species present in chronic rhinosinusitis. Front. Microbiol. 10, 2325 (2019).
pubmed: 31708879 pmcid: 6821979 doi: 10.3389/fmicb.2019.02325
Sokovic, M., Glamoclija, J., Marin, P. D., Brkic, D. & van Griensven, L. J. Antibacterial effects of the essential oils of commonly consumed medicinal herbs using an in vitro model. Molecules 15, 7532–7546 (2010).
pubmed: 21030907 pmcid: 6259430 doi: 10.3390/molecules15117532
Ghavam, M., Manca, M. L., Manconi, M. & Bacchetta, G. Chemical composition and antimicrobial activity of essential oils obtained from leaves and flowers of Salvia hydrangea DC. ex Benth. Sci. Rep. 10, 15647 (2020).
pubmed: 32973295 pmcid: 7519093 doi: 10.1038/s41598-020-73193-y
Niedzielski, A., Chmielik, L. P. & Stankiewicz, T. The formation of biofilm and bacteriology in otitis media with effusion in children: A prospective cross-sectional study. Int. J. Environ. Res. Public Health 18, 3555 (2021).
pubmed: 33808050 pmcid: 8037871 doi: 10.3390/ijerph18073555
Daniel, M., Imtiaz-Umer, S., Fergie, N., Birchall, J. P. & Bayston, R. Bacterial involvement in otitis media with effusion. Int. J. Pediatric Otorhinolaryngol. 76, 1416–1422 (2012).
doi: 10.1016/j.ijporl.2012.06.013
Hall-Stoodley, L. & Stoodley, P. Evolving concepts in biofilm infections. Cell. Microbiol. 11, 1034–1043 (2009).
pubmed: 19374653 doi: 10.1111/j.1462-5822.2009.01323.x
Merghni, A. et al. Assessment of the antibiofilm and antiquorum sensing activities of Eucalyptus globulus essential oil and its main component 1,8-cineole against methicillin-resistant Staphylococcus aureus strains. Microb. Pathog. 118, 74–80 (2018).
pubmed: 29522803 doi: 10.1016/j.micpath.2018.03.006
Landeo-Villanueva, G. E. et al. Inhibitory activity of essential oils of Mentha spicata and Eucalyptus globulus on biofilms of Streptococcus mutans in an in vitro model. Antibiotics 12, 369 (2023).
pubmed: 36830281 pmcid: 9952483 doi: 10.3390/antibiotics12020369
Addo, K. A., Li, L., Li, H., Yu, Y. & Xiao, X. Osmotic stress relief antibiotic tolerance of 1,8-cineole in biofilm persister cells of Escherichia coli O157:H7 and expression of toxin-antitoxin system genes. Microb. Pathog. 173, 105883 (2022).
pubmed: 36396071 doi: 10.1016/j.micpath.2022.105883
Vazquez, N. M., Mariani, F., Torres, P. S., Moreno, S. & Galvan, E. M. Cell death and biomass reduction in biofilms of multidrug resistant extended spectrum beta-lactamase-producing uropathogenic Escherichia coli isolates by 1,8-cineole. PloS One 15, e0241978 (2020).
pubmed: 33152054 pmcid: 7644070 doi: 10.1371/journal.pone.0241978
Hendry, E. R., Worthington, T., Conway, B. R. & Lambert, P. A. Antimicrobial efficacy of eucalyptus oil and 1,8-cineole alone and in combination with chlorhexidine digluconate against microorganisms grown in planktonic and biofilm cultures. J. Antimicrob. Chemother. 64, 1219–1225 (2009).
pubmed: 19837714 doi: 10.1093/jac/dkp362
Annapoorani, A., Jabbar, A. K., Musthafa, S. K., Pandian, S. K. & Ravi, A. V. Inhibition of quorum sensing mediated virulence factors production in urinary pathogen serratia marcescens PS1 by marine sponges. Indian J. Microbiol. 52, 160–166 (2012).
pubmed: 23729876 pmcid: 3386442 doi: 10.1007/s12088-012-0272-0
LaSarre, B. & Federle, M. J. Exploiting quorum sensing to confuse bacterial pathogens. Microbiol. Mol. Biol. Rev. MMBR 77, 73–111 (2013).
pubmed: 23471618 doi: 10.1128/MMBR.00046-12
Packiavathy, I. A., Priya, S., Pandian, S. K. & Ravi, A. V. Inhibition of biofilm development of uropathogens by curcumin - an anti-quorum sensing agent from Curcuma longa. Food Chem. 148, 453–460 (2014).
pubmed: 24262582 doi: 10.1016/j.foodchem.2012.08.002
Li, L. et al. Antibacterial activity of leaf essential oil and its constituents from Cinnamomum longepaniculatum. Int. J. Clin. Exp. Med. 7, 1721–1727 (2014).
pubmed: 25126170 pmcid: 4132134
Kaltschmidt, B. P. et al. Preparation of terpenoid-invasomes with selective activity against S. aureus and characterization by cryo transmission electron microscopy. Biomedicines 8, 105 (2020).
pubmed: 32369920 pmcid: 7277086 doi: 10.3390/biomedicines8050105
Vijay, A. & Valdes, A. M. Role of the gut microbiome in chronic diseases: A narrative review. Eur. J. Clin. Nutr. 76, 489–501 (2022).
pubmed: 34584224 doi: 10.1038/s41430-021-00991-6
Arumugam, M. et al. Enterotypes of the human gut microbiome. Nature 473, 174–180 (2011).
pubmed: 21508958 pmcid: 3728647 doi: 10.1038/nature09944
Wu, M. & Kasper, D. L. Fiber sets up the battleground for intestinal prevotella. Cell Host Microbe 28, 776–777 (2020).
pubmed: 33301716 doi: 10.1016/j.chom.2020.11.010
Agus, A., Clement, K. & Sokol, H. Gut microbiota-derived metabolites as central regulators in metabolic disorders. Gut 70, 1174–1182 (2021).
pubmed: 33272977 doi: 10.1136/gutjnl-2020-323071
Tajiri, K. & Shimizu, Y. Branched-chain amino acids in liver diseases. Transl. Gastroenterol. Hepatol. 3, 47 (2018).
pubmed: 30148232 pmcid: 6088198 doi: 10.21037/tgh.2018.07.06
Roager, H. M., Licht, T. R., Poulsen, S. K., Larsen, T. M. & Bahl, M. I. Microbial enterotypes, inferred by the prevotella-to-bacteroides ratio, remained stable during a 6-month randomized controlled diet intervention with the new nordic diet. Appl. Environ. Microbiol. 80, 1142–1149 (2014).
pubmed: 24296500 pmcid: 3911217 doi: 10.1128/AEM.03549-13
Lim, G. B. Improved gut microbiota profile in individuals with obesity taking statins. Nat. Rev. Cardiol. 17, 385 (2020).
pubmed: 32439977 doi: 10.1038/s41569-020-0396-6
Wolf, E. A. et al. Culturomics approaches expand the diagnostic accuracy for sexually transmitted infections. Int. J. Mol. Sci. 22, 10815 (2021).
pubmed: 34639153 pmcid: 8509341 doi: 10.3390/ijms221910815
Graspeuntner, S. et al. Microbiota-based analysis reveals specific bacterial traits and a novel strategy for the diagnosis of infectious infertility. PloS One 13, e0191047 (2018).
pubmed: 29315330 pmcid: 5760088 doi: 10.1371/journal.pone.0191047
Graspeuntner, S., Loeper, N., Kunzel, S., Baines, J. F. & Rupp, J. Selection of validated hypervariable regions is crucial in 16S-based microbiota studies of the female genital tract. Sci. Rep. 8, 9678 (2018).
pubmed: 29946153 pmcid: 6018735 doi: 10.1038/s41598-018-27757-8
Schloss, P. D. et al. Introducing mothur: Open-source, platform-independent, community-supported software for describing and comparing microbial communities. Appl. Environ. Microbiol. 75, 7537–7541 (2009).
pubmed: 19801464 pmcid: 2786419 doi: 10.1128/AEM.01541-09
Parks, D. H. et al. A standardized bacterial taxonomy based on genome phylogeny substantially revises the tree of life. Nat. Biotechnol. 36, 996–1004 (2018).
pubmed: 30148503 doi: 10.1038/nbt.4229
McDonald, D. et al. An improved Greengenes taxonomy with explicit ranks for ecological and evolutionary analyses of bacteria and archaea. ISME J. 6, 610–618 (2012).
pubmed: 22134646 doi: 10.1038/ismej.2011.139
Rognes, T., Flouri, T., Nichols, B., Quince, C. & Mahe, F. VSEARCH: A versatile open source tool for metagenomics. PeerJ 4, e2584 (2016).
pubmed: 27781170 pmcid: 5075697 doi: 10.7717/peerj.2584
Afgan, E. et al. The Galaxy platform for accessible, reproducible and collaborative biomedical analyses: 2018 update. Nucleic Acids Res. 46, W537–W544 (2018).
pubmed: 29790989 pmcid: 6030816 doi: 10.1093/nar/gky379
Segata, N. et al. Metagenomic biomarker discovery and explanation. Genome Biol. 12, R60 (2011).
pubmed: 21702898 pmcid: 3218848 doi: 10.1186/gb-2011-12-6-r60

Auteurs

Anke Leichtle (A)

Department of Otorhinolaryngology, University of Luebeck, 23538, Lübeck, Germany.

Mariia Lupatsii (M)

Department of Infectious Diseases and Microbiology, University of Luebeck, Lübeck, Germany.

Simon Graspeuntner (S)

Department of Infectious Diseases and Microbiology, University of Luebeck, Lübeck, Germany.

Stephanie Jeschke (S)

Department of Otorhinolaryngology, University of Luebeck, 23538, Lübeck, Germany.

Zuzana Penxová (Z)

Department of Otorhinolaryngology, University of Luebeck, 23538, Lübeck, Germany.

Arwa Kurabi (A)

Department of Surgery/ Otolaryngology, University of California San Diego, La Jolla, USA.

Allen Frederic Ryan (AF)

Department of Surgery/ Otolaryngology, University of California San Diego, La Jolla, USA.

Jan Rupp (J)

Department of Infectious Diseases and Microbiology, University of Luebeck, Lübeck, Germany.

Ralph Pries (R)

Department of Otorhinolaryngology, University of Luebeck, 23538, Lübeck, Germany.

Karl-Ludwig Bruchhage (KL)

Department of Otorhinolaryngology, University of Luebeck, 23538, Lübeck, Germany. karl-ludwig.bruchhage@uksh.de.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH